Evidence map›Paper›PMID 42337036›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Diagnostic accuracy of

Chloé Quéré, Valérie Devauchelle-Pensec, Philippe Thuillier, Florent Besson, Théo Guichaoua, Arthur Le Madec, Raphaële Seror, Marie Pean de Ponfilly, Daniel Wendling, Hatem Boulahdour and 16 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Chloé QuéréDepartment of Molecular Imaging and Radiotheranostics, Cancer and Imaging Institute, Brest University Hospital (CHRU Brest) - Cavale Blanche, Brest, France. chloe.quere@chu-brest.fr.ORCID 0009-0008-0207-6259
Valérie Devauchelle-PensecUniversity of Western Brittany (UBO), Brest, France.
Philippe ThuillierUniversity of Western Brittany (UBO), Brest, France.
Florent BessonDepartment of Nuclear Medicine-Molecular Imaging, DMU Smart Imaging, Hôpitaux Universitaires Paris-Saclay, AP-HP, CHU Bicêtre, Le Kremlin-Bicêtre, France.
Théo GuichaouaUniversity of Western Brittany (UBO), Brest, France.
Arthur Le MadecDepartment of rheumatology, Brest University Hospital, Brest, France.
Raphaële SerorDepartment of rheumatology, Bicêtre Hospital, Kremlin-Bicêtre, France.
Marie Pean de PonfillyDepartment of rheumatology, APHP Bichat, Paris, France.
Daniel WendlingDepartment of rheumatology, University Marie et Louis Pasteur, Besançon University Hospital, Besançon, France.
Hatem BoulahdourNuclear Medicine department, Besançon University Hospital, Besançon, France.
Tristan PascartDepartment of rheumatology, Saint-Philibert Hospital, Lille Catholic, Lille, France.
Aurore PacaudDepartment of rheumatology, Saint-Philibert Hospital, Lille Catholic, Lille, France.
Alban BailliezNuclear Medicine department, Saint-Philibert Hospital, Lille Catholic, Lille, France.
Thomas EugèneNuclear Medicine department, Nantes University Hospital, Nantes, France.
Sebastien OttavianiDepartment of rheumatology, APHP Bichat, Paris, France.
Philippe DieudeDepartment of rheumatology, APHP Bichat, Paris, France.
Khadija Ben AliNuclear Medicine department, APHP Bichat, Paris, France.
Frederic PaychaNuclear Medicine department, APHP Lariboisière, Paris, France.
Augustin LatourteDepartment of rheumatology, APHP Lariboisière, Paris, France.
Laurinda CarreDepartment of rheumatology, APHP Lariboisière, Paris, France.
Bruno FautrelDepartment of rheumatology, APHP Pitié-Salpétrière, Paris, France.
Patrice CacoubDepartment of internal medicine and clinical immunology, APHP Pitié-Salpétrière, Paris, France.
Serge DesarnaudNuclear Medicine department, APHP Pitié-Salpétrière, Paris, France.
Pierre-Yves SalaünDepartment of Molecular Imaging and Radiotheranostics, Cancer and Imaging Institute, Brest University Hospital (CHRU Brest) - Cavale Blanche, Brest, France.
Ronan AbgralDepartment of Molecular Imaging and Radiotheranostics, Cancer and Imaging Institute, Brest University Hospital (CHRU Brest) - Cavale Blanche, Brest, France.
Solène QuerellouDepartment of Molecular Imaging and Radiotheranostics, Cancer and Imaging Institute, Brest University Hospital (CHRU Brest) - Cavale Blanche, Brest, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the diagnostic accuracy of

methodsThis retrospective multicentre study included 232 patients with inflammatory rheumatic diseases (150 PMR, 50 axial spondylarthritis AxSpA and 32 other rheumatic diseases) divided into training and external validation cohorts. The gold standard final diagnoses were those that were upheld by an experienced rheumatologist, at least at 6 months' follow up, taking into account all available information (clinical data and evolution, radiological, biological, PET-CT) but blinded for the scoring system.

resultsThe highest diagnostic accuracy for PMR was observed with the Leuven, Leuven/Groningen, Besançon and Brest scores (AUC 0.83-0.89 in training and 0.67-0.69 in external validation cohorts). The Leuven/Groningen sensitivity and specificity were respectively 94.7%/67.9% (training) and 72.2%/55.2% (validation). The sensitivity of Pean de Ponfilly score was lower (78.9% (training) and 55.6% (validation)). The diagnostic performance of Brest was quite similar to Leuven scores (96.4%/66% in training; 86.1%/51.7% in validation). Heidelberg and Saint-Étienne algorithms demonstrated high sensitivity with low specificity.

conclusionLeuven/Groningen and Brest scores may represent promising tools for distinguishing PMR from other rheumatic diseases, given their ease of use and diagnostic performance.

Indexed as

Fluorodeoxyglucose F18Polymyalgia RheumaticaPositron Emission Tomography Computed TomographyRheumatic DiseasesAgedAged, 80 and overDiagnosis, DifferentialFemaleHumansMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesSensitivity and SpecificityFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET-CTAxial SpondylarthritisDiagnostic accuracyInflammatory rheumatic diseasePolymyalgia rheumaticaScores

Identifiers

PMID42337036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.